TDP-43 (TAR DNA-binding protein-43, encoded by the TARDBP gene) is a heterogeneous nuclear ribonucleoprotein (hnRNP) that plays critical roles in RNA processing, including splicing, stability, transport, and translation. Pathological aggregation of TDP-43 in neurons and glia is the hallmark of amyotrophic lateral sclerosis (ALS) and the majority of frontotemporal dementia (FTD) cases, making TDP-43 one of the most important proteins in neurodegenerative disease research.
TDP-43 is a 414-amino acid protein that belongs to the hnRNP family. Originally characterized as a transcriptional repressor binding to the TAR element of HIV-1, TDP-43 has emerged as a fundamental RNA-binding protein with roles in nearly every aspect of RNA metabolism. The discovery of TARDBP mutations as a cause of familial ALS in 2008 established TDP-43 as a central player in neurodegeneration. This page provides comprehensive information about TDP-43's structure, functions, disease mechanisms, and therapeutic strategies.
{{Infobox .infobox .infobox-protein
| protein_name = TDP-43 Protein
| gene = TARDBP
| uniprot_id = Q13148
| molecular_weight = ~44 kDa
| localization = Nucleus, cytoplasm (nucleocytoplasmic shuttling)
| family = hnRNP family, RRM domain proteins
}}
TDP-43 contains several distinct functional domains:
N-terminal domain (residues 1-102): Contains a nuclear localization signal (NLS) and mediates protein-protein interactions. This domain is relatively conserved and participates in homodimerization.
RNA recognition motif 1 (RRM1, residues 106-176): The primary RNA-binding domain with the canonical RNP1 and RNP2 sequences. Binds UG-rich RNA sequences with high affinity.
RNA recognition motif 2 (RRM2, residues 191-259): A second RRM that contributes to RNA binding specificity and affinity. The two RRMs work cooperatively.
Glycine-rich low-complexity domain (residues 274-414): This C-terminal region is prion-like and prone to aggregation. Contains the QGSY region (Gln-Gly-Ser-Tyr) characteristic of many RNA-binding proteins. Most ALS/FTD mutations cluster here.
Nuclear export signal (NES): A leucine-rich sequence enabling cytoplasmic localization under certain conditions.
TDP-43 undergoes numerous modifications:
TDP-43 regulates alternative splicing of numerous transcripts:
TDP-43 dynamically shuttles between nucleus and cytoplasm:
Over 50 pathogenic TARDBP mutations have been identified in ALS:
Loss of normal function:
Gain of toxic function:
Stress granule dynamics:
Nucleocytoplasmic transport defects:
The study of Tardbp Tdp 43 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133. PMID:17023659
Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205-1208. PMID:19251627
Buratti E, Baralle M. Molecular targets of TDP-43 dysfunction in ALS. Cold Spring Harbor Perspectives in Medicine. 2018;8(11):a024554. PMID:29325149
Ratti A, Buratti E. Molecular biology and pathology of TDP-43: update on the aggregation-prone C-terminal fragment and the effect of disease mutations. Neurobiology of Disease. 2022;171:105783. PMID:35472684
Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416-438. PMID:23931993
Chen HJ, Topp SD, Hui HS, et al. RRM mutation in ALS identifies a functional domain and expanded therapeutic targeting. Neuron. 2019;102(2):321-338.e8. PMID:30819358
Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 aggregation and neuronal damage in ALS. Biophysical Reviews. 2019;11(5):683-698. PMID:31407121
Boeynaems S, Bogaert E, Van Damme P, Van Den Bosch L. Inside out: the role of nucleocytoplasmic transport in ALS and FTD. Acta Neuropathologica. 2016;132(2):159-173. PMID:27251175
Liu Y, Qiu H, Cheng Q. The roles of TDP-43 in Alzheimer's disease. Frontiers in Aging Neuroscience. 2020;12:20. PMID:32116697
Vats A, Meyer K, Liao J, et al. TDP-43 and Alzheimer's disease pathology in the brain. Brain Pathology. 2023;33(2):e13126. PMID:36537586